April 14, 2019 / 10:09 PM / 8 days ago

Catalent to buy Paragon Bioservices for $1.2 bln -WSJ

April 14 (Reuters) - Drug developer Catalent Inc has agreed to buy privately held Paragon Bioservices Inc for $1.2 billion, the Wall Street Journal reported on Sunday, citing people familiar with the matter.

An all-cash deal between the companies is expected to be announced on Monday morning, the Journal said here (Reporting by Ismail Shakil in Bengaluru Editing by Chris Reese)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below